Cingulate Inc. SEC filings CING
Cingulate Inc. has 493 filings in SEC EDGAR's recent list, going back to May 24, 2021. Its latest annual report, Form ARS, was filed on May 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | May 29, 2026 | May 29, 2026 |
| DEFA14A | Additional proxy material | May 29, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 18, 2026 | May 18, 2026 |
| DEFA14A | Additional proxy material | Mar 18, 2026 | — |
| DEF 14A | Proxy statement | Mar 2, 2026 | Mar 2, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 18, 2026 | Feb 18, 2026 |
| DEF 14A | Proxy statement | Aug 15, 2025 | Aug 15, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 5, 2025 | Aug 5, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2025 | Apr 15, 2025 |
| DEFA14A | Additional proxy material | Aug 23, 2024 | — |
| DEF 14A | Proxy statement | Jul 22, 2024 | Jul 22, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 12, 2024 | Jul 12, 2024 |
| DEFA14A | Additional proxy material | Jul 12, 2024 | — |
| DEF 14A | Proxy statement | Jun 28, 2024 | Jun 28, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 18, 2024 | Jun 18, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| DEF 14A | Proxy statement | Oct 2, 2023 | Oct 2, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 22, 2023 | Sep 22, 2023 |
| DEFA14A | Additional proxy material | May 5, 2023 | — |
| DEF 14A | Proxy statement | May 5, 2023 | May 5, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2023 | Apr 26, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Apr 22, 2022 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CING (Nasdaq), CINGW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Kansas City, KS
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1862150
- Former names
- Cingulate Inc. (until Oct 2, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.